Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT

OBJECTIVE: To assess long-term (2 years) effects of bimagrumab in participants with sporadic inclusion body myositis (sIBM). METHODS: Participants (aged 36–85 years) who completed the core study (RESILIENT [Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, M...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neurology
Autores principales: Amato, Anthony A., Hanna, Michael G., Machado, Pedro M., Badrising, Umesh A., Chinoy, Hector, Benveniste, Olivier, Karanam, Ananda Krishna, Wu, Min, Tankó, László B., Schubert-Tennigkeit, Agnes Annette, Papanicolaou, Dimitris A., Lloyd, Thomas E., Needham, Merrilee, Liang, Christina, Reardon, Katrina A., de Visser, Marianne, Ascherman, Dana P., Barohn, Richard J., Dimachkie, Mazen M., Miller, James A.L., Kissel, John T., Oskarsson, Björn, Joyce, Nanette C., Van den Bergh, Peter, Baets, Jonathan, De Bleecker, Jan L., Karam, Chafic, David, William S., Mirabella, Massimiliano, Nations, Sharon P., Jung, Hans H., Pegoraro, Elena, Maggi, Lorenzo, Rodolico, Carmelo, Filosto, Massimiliano, Shaibani, Aziz I., Sivakumar, Kumaraswamy, Goyal, Namita A., Mori-Yoshimura, Madoka, Yamashita, Satoshi, Suzuki, Naoki, Aoki, Masashi, Katsuno, Masahisa, Morihata, Hirokazu, Murata, Kenya, Nodera, Hiroyuki, Nishino, Ichizo, Romano, Carla D., Williams, Valerie S.L., Vissing, John, Zhang Auberson, Lixin
Formato: Artigo
Lenguaje:Inglês
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8032371/
https://ncbi.nlm.nih.gov/pubmed/33597289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000011626
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares